Clinical Trial Agreement Template for Singapore

A Clinical Trial Agreement is a legally binding contract that governs the conduct of human biomedical research in Singapore. This essential document establishes the framework between sponsors, research institutions, and principal investigators, ensuring all parties understand their roles, responsibilities, and obligations throughout the clinical trial process. Under Singapore law, these agreements are mandatory for conducting any human biomedical research and must comply with strict regulatory requirements.

When do you need this document?

You need a Clinical Trial Agreement whenever conducting human biomedical research in Singapore involving pharmaceutical products, medical devices, or therapeutic interventions. This includes Phase I through Phase IV clinical trials, investigator-initiated studies, and collaborative research between public institutions and private sponsors. The agreement is required before enrolling any participants and must be in place when seeking regulatory approvals from Singapore's Health Sciences Authority. You also need this document when conducting multi-site studies across different healthcare institutions in Singapore, as each site requires a separate agreement addressing site-specific requirements and local compliance obligations.

Key legal considerations

Several critical legal elements must be addressed in your Clinical Trial Agreement. Patient safety provisions must establish clear protocols for adverse event reporting, safety monitoring, and emergency procedures in compliance with Singapore Guidelines for Good Clinical Practice. Data protection clauses must ensure compliance with the Personal Data Protection Act 2012, covering collection, storage, and transfer of participant information. Intellectual property provisions should clearly define ownership of study data, research findings, and any resulting patents or publications. Insurance and indemnity clauses must provide adequate coverage for participants and protect institutions from liability. Financial arrangements should detail payment schedules, budget allocations, and cost responsibilities between parties.

Legal requirements in Singapore

Singapore's regulatory framework requires Clinical Trial Agreements to comply with multiple legislative instruments. Under the Human Biomedical Research Act, all agreements must demonstrate ethical approval from relevant Institutional Review Boards and ensure participant welfare protection. The Health Products Act mandates compliance with HSA licensing requirements and Good Clinical Practice standards for pharmaceutical trials. The Medicines Act governs trials involving therapeutic products and requires proper regulatory notifications. Additionally, agreements must incorporate Singapore Guidelines for Good Clinical Practice, ensuring international standards are met while addressing local regulatory nuances. The agreement must also establish clear reporting mechanisms to HSA and other relevant authorities, define audit and inspection procedures, and ensure all research personnel have appropriate qualifications and training certifications required under Singapore law.